Maria Jose Alonso, PhD

University of Santiago de Compostela

María José Alonso’s lab has pioneered numerous discoveries in the field of Nanopharmaceutical Technology and nanomedicine. She has coordinated several research consortia financed by the WHO, the Gates Foundation and the European Commission. She is the author of 290 scientific contributions with more than 29,400 cites (H factor 90) and the inventor of 22 patent families. Because of the quality of her scientific articles she has been among the TOP TEN in Pharmacology (Times Higher Education international ranking, 2010).

Recently, she was nominated  as one of the most influential researchers in the field of Biopharmaceuticals (The Power List-The Medicine Maker, 2020) She has served to the Release Society (CRS) for 15 years and she is currently Past President of the Controlled Release Society (CRS). She is also Editor-in-Chief of
the Drug Delivery and Translational Research, an official journal of the CRS, and she is part of the editorial board of 11 journals.

She was the Vice-rector of Research and Innovation of the USC (2006-10). She has received 30 awards, among them the Founders Award of the CRS. She is a fellow of the American Institute for Medical and Biological Engineering (AIMBE) and a Fellow of the Controlled Release Society, a member of three Academies in Spain and a member of the US National Academy of Medicine (NAM).